Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results.
The specialist dermatology and oncology company said it achieved first revenues from skin+CELL direct-to-consumer sales and completed a strategic acquisition of Swiss skincare brand énielle. It also said it raised gross proceeds of £355,000 through unsecured convertible loan notes.
For best results when printing this announcement, please click on link below: RNS Number: 0602W India Capital Growth Fund Limited 24 September 2026 INDIA CAPITAL GROWTH FUND LIMITED Interim Results for the six months ended 30 June 2026 24 September 2026, London - India Capital Growth Fund ("ICGF" or "the Company"), the
Cosmos Health builds contract manufacturing orderbook to over 25 million units, positioned to generate over $10 million in recurring annual profit